medicalxpress - A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications were about 30% less likely to develop breast cancer than those who did not take GLP-1 medications, according to research presente…
AI Summary: A large observational cohort study reported an association between GLP‑1 agonist use and a lower incidence of breast cancer. The result is intriguing and may spur biological investigation, but researchers caution against causal claims—confounding and indication bias mean randomized trials would be required to confirm any protective effect.
Zanidatamab improves PFS over trastuzumab in HER2 GEA / 2 days
MAGE‑A4/A8 TCR bispecific T‑cell engager shows activity in solid tumors / 2 days
Teclistamab outperforms standard regimens in earlier-line relapsed myeloma / 4 days
Common asthma drug may overcome immunotherapy resistance in cancers / 13 days
Retifanlimab plus chemotherapy extends survival in advanced squamous anal cancer / 16 days
Zoldonrasib shows durable responses in KRAS G12D lung cancer / 6 wks
James P. Allison wins AACR lifetime achievement award / 7 wks
StackHealth RSS

StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.